Global & Disaster Medicine

Archive for the ‘WHO’ Category

Mozambique: A successful six-day emergency cholera vaccination campaign that reached more than 800 000 people

WHO

10 April 2019, Maputo – The Ministry of Health in Mozambique has concluded a successful six-day emergency cholera vaccination campaign that reached more than 800 000 people in four districts affected by Cyclone Idai.

The campaign was supported by around 1200 community volunteers and partners including the World Health Organization (WHO), UNICEF, Médecins Sans Frontières (MSF), International Federation of the Red Cross and Red Crescent Societies (IFRC) and Save the Children.

“From start to finish, this campaign was one of the fastest ever, thanks to experienced people at the Ministry of Health, who knew there was a high risk of a cholera outbreak and made a rapid request for the vaccines as soon as the cyclone hit,” says Dr Djamila Cabral, Head of the WHO office in Mozambique. “The Ministry did an excellent job organizing the campaign and reaching so many people in such a short time. The oral cholera vaccine is one of the vital measures that can help save lives and stop the spread of this terrible disease during an outbreak.”

The oral cholera vaccines, donated by Gavi from the Global Cholera Vaccine Stockpile, arrived in Beira on Tuesday 2 April and, within 24 hours, began reaching people in need.

The vaccines were given to communities identified by the Government at highest risk – those without access to safe water and sanitation – in Beira, Dondo, Nhamatanda and Buzi districts.

Vaccine uptake has been very high and the campaign has been well received by the communities. Remaining vaccines will be used for other at-risk communities that were not reached by the initial campaign.

People develop protection against cholera approximately 7 days after receiving the vaccine. One dose of this oral vaccine provides around 85% protection against cholera for 6 months.

“Controlling cholera in these areas will reduce the risk to the rest of the population because fewer people will be taking it back and forth into the wider community,” says WHO cholera vaccination expert, Kate Alberti, who was deployed to Beira to support the Ministry of Health to organize the campaign.

Dr Nazira Abdula, Minister of Health of Mozambique, acknowledged the great support of WHO and partners for the vaccination campaign. “It’s very difficult to roll out a campaign of this scope in only three days,” she says.

WHO’s Dr Cabral adds: “This campaign would not have been possible without the strong engagement of the local authorities and the communities themselves. The number of volunteers is impressive and, wherever they go, there has been very strong uptake of the vaccine. Everyone is very keen to make this a success to stop cholera in its tracks.”

Since Cyclone Idai struck Mozambique on 14 March, hundreds of thousands of people have been living in temporary settlements without access to safe water and sanitation. The Ministry of Health declared a cholera outbreak on 27 March and, as of 8 April, had reported more than 3577 cases and 6 deaths.

The cholera vaccine is just one tool for the outbreak response. Currently 12 cholera treatment centres, with 500-bed capacity, have been set up by the national authorities and international partners to serve the affected communities. Partners are also supporting the local authorities to provide access to safe water and sanitation in settlements and communities across Sofala Province.

Cholera is endemic in several parts of Sofala province and the cholera outbreak that developed post-Cyclone Idai acts as a reminder that sustainable access to safe water, sanitation, and hygiene (WASH) is the long-term solution to controlling cholera. Acknowledging that every case of cholera is preventable, the Global Task Force on Cholera Control is implementing a Cholera Global Roadmap to 2030, which calls upon development partners and donors to support countries to reduce cholera deaths by 90% by 2030.

 


WHO launches new global influenza strategy

WHO

WHO launches new global influenza strategy

11 March 2019

News Release
Geneva

WHO today released a Global Influenza Strategy for 2019-2030 aimed at protecting people in all countries from the threat of influenza. The goal of the strategy is to prevent seasonal influenza, control the spread of influenza from animals to humans, and prepare for the next influenza pandemic.

“The threat of pandemic influenza is ever-present.” said WHO Director-General Dr Tedros Adhanom Ghebreyesus. “The on-going risk of a new influenza virus transmitting from animals to humans and potentially causing a pandemic is real.   The question is not if we will have another pandemic, but when.  We must be vigilant and prepared – the cost of a major influenza outbreak will far outweigh the price of prevention.”

Influenza remains one of the world’s greatest public health challenges. Every year across the globe, there are an estimated 1 billion cases, of which 3 to 5 million are severe cases, resulting in 290 000 to 650 000 influenza-related respiratory deaths. WHO recommends annual influenza vaccination as the most effective way to prevent influenza. Vaccination is especially important for people at higher risk of serious influenza complications and for health care workers.

The new strategy is the most comprehensive and far-reaching that WHO has ever developed for influenza.  It outlines a path to protect populations every year and helps prepare for a pandemic through strengthening routine programmes. It has two overarching goals:
 

  1. Build stronger country capacities for disease surveillance and response, prevention and control, and preparedness. To achieve this, it calls for every country to have a tailored influenza programme that contributes to national and global preparedness and health security.
  2. Develop better tools to prevent, detect, control and treat influenza, such as more effective vaccines, antivirals and treatments, with the goal of making these accessible for all countries.

“With the partnerships and country-specific work we have been doing over the years, the world is better prepared than ever before for the next big outbreak, but we are still not prepared enough,” said Dr Tedros. “This strategy aims to get us to that point. Fundamentally, it is about preparing health systems to manage shocks, and this only happens when health systems are strong and healthy themselves.”

To successfully implement this strategy, effective partnerships are essential.  WHO will expand partnerships to increase research, innovation and availability of new and improved global influenza tools to benefit all countries.  At the same time WHO will work closely with countries to improve their capacities to prevent and control influenza.

The new influenza strategy builds on and benefits from successful WHO programmes.  For more than 65 years, the Global Influenza Surveillance and Response System (GISRS), comprised   of WHO Collaborating Centres and national influenza centres, have worked together to monitor seasonal trends and potentially pandemic viruses. This system serves as the backbone of the global alert system for influenza.

Important to the strategy is the on-going success of the Pandemic Influenza Preparedness Framework, a unique access and benefit sharing system that supports the sharing of potentially pandemic viruses, provides access to life saving vaccines and treatments in the event of a pandemic and supports the building of pandemic preparedness capacities in countries through partnership contributions from industry.

The strategy meets one of WHO’s mandates to improve core capacities for public health, and increase global preparedness and was developed through a consultative process with input from Member States, academia, civil society, industry, and internal and external experts.

Supporting countries to strengthen their influenza capacity will have collateral benefits in detecting infection in general, since countries will be able to better identify other infectious diseases like Ebola or Middle East respiratory syndrome-related coronavirus (MERS-CoV).

Through the implementation of the new WHO global influenza strategy, the world will be closer to reducing the impact of influenza every year and be more prepared for an influenza pandemic and other public health emergencies.


Streamlining The WHO: Can it be done?

NYT

“……The World Health Organization …..announced a long-awaited restructuring intended to streamline the agency — and strongly hinted that it intended to shake up some staffers’ resistance to change.

The announcement, made in a lengthy and mostly cheerful speech delivered jointly by the organization’s director general, Tedros Adhanom Ghebreyesus, and the directors of the agency’s six regional offices, aims to serve the W.H.O.’s new targets: to get affordable health care to the world’s poorest 1 billion people; to better protect them against epidemics; and to help them enjoy better health, including protection from noncommunicable diseases like cancer…..”


The WHO’s ambitious “triple billion” targets

WHO

WHO unveils sweeping reforms in drive towards “triple billion” targets

6 March 2019

News Release
Geneva

WHO today announced the most wide-ranging reforms in the Organization’s history to modernize and strengthen the institution to play its role more effectively and efficiently as the world’s leading authority on public health.

The changes are designed to support countries in achieving the ambitious “triple billion” targets that are at the heart of WHO’s strategic plan for the next five years: one billion more people benefitting from universal health coverage (UHC); one billion more people better protected from health emergencies; and one billion more people enjoying better health and well-being.

These changes include:

  • Aligning WHO’s processes and structures with the “triple billion” targets and the Sustainable Development Goals by adopting a new structure and operating model to align the work of headquarters, regional offices and country offices, and eliminate duplication and fragmentation.

  • Reinforcing WHO’s normative, standard-setting work, supported by a new Division of the Chief Scientist and improved career opportunities for scientists.

  • Harnessing the power of digital health and innovation by supporting countries to assess, integrate, regulate and maximize the opportunities of digital technologies and artificial intelligence, supported by a new Department of Digital Health.

  • Making WHO relevant in all countries by overhauling the Organization’s capabilities to engage in strategic policy dialogue. This work will be supported by a new Division of Data, Analytics and Delivery to significantly enhance the collection, storage, analysis and usage of data to drive policy change in countries. This division will also track and strengthen the delivery of WHO’s work by monitoring progress towards the “triple billion targets” and identifying roadblocks and solutions.

  • Investing in a dynamic and diverse workforce through new initiatives including the WHO Academy, a proposed state-of-the-art school to provide new learning opportunities for staff and public health professionals globally. Other measures include a streamlined recruitment process to cut hiring time in half,  management trainings, new opportunities for national professional officers, and previously-announced improvements in conditions for interns.

  • Strengthening WHO’s work to support countries in preventing and mitigating the impact of outbreaks and other health crises by creating a new Division of Emergency Preparedness, as a complement to WHO’s existing work on emergency response.

  • Reinforcing a corporate approach to resource mobilization aligned with strategic objectives and driving new fundraising initiatives to diversify WHO’s funding base, reduce its reliance on a small number of large donors and strengthen its long-term financial stability.

“The changes we are announcing today are about so much more than new structures, they’re about changing the DNA of the organization to deliver a measurable impact in the lives of the people we serve,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “Our vision remains the same as it was when we were founded in 1948: the highest attainable standard of health for all people. But the world has changed, which is why we have articulated a new mission statement for what the world needs us to do now: to promote health, keep the world safe and serve the vulnerable.”

The new measures were developed following an extensive period of consultation with staff, and were developed jointly by WHO’s Global Policy Group, which consists of the Director-General and each of the organization’s six regional directors: Dr Matshidiso Moeti (Regional Director for Africa), Dr Carissa Etienne (Regional Director for the Americas), Dr Poonam Khetrapal Singh (Regional Director for South-East Asia), Dr Zsuzsanna Jakab (Regional Director for Europe), Dr Ahmed Al-Mandhari (Regional Director for the Eastern Mediterranean) and Dr Takeshi Kasai (Regional Director for the Western Pacific).

WHO’s new corporate structure is based on four pillars which will be mirrored throughout the organization.

The Programmes pillar will support WHO’s work on universal health coverage and healthier populations. The Emergencies pillar will be responsible for WHO’s critical health security responsibilities, both in responding to health crises and helping countries prepare for them. The External Relations and Governance pillar will centralize and harmonize WHO’s work on resource mobilization, communications. The Business Operations pillar will likewise ensure more professionalized delivery of key corporate functions such as budgeting, finance, human resources and supply chain.

The four pillars will be supplemented by the Division of the Chief Scientist at WHO Headquarters in Geneva to strengthen WHO’s core scientific work and ensure the quality and consistency of WHO’s norms and standards. 

Underpinning the new structure, 11 business processes have been redesigned, including planning, resource mobilization, external and internal communications, recruitment, supply chain, performance management, norms and standards, research, data and technical cooperation.

The Global Policy Group stressed the role of working with partners. Dr Tedros said WHO must develop a new mindset to seek out and build partnerships that harness the combined strength of the global health community – both in the public and private sectors. One example of this is a new Global Action Plan for Healthy Lives and Well-Being for All, under which 12 partner organizations are working together to achieve health-related Sustainable Development Goals.


WHO’s Health Emergencies Programme

WHO

What is WHO’s role in emergencies?

WHO is committed to saving lives and reducing suffering during times of crisis – whether caused by conflict, disease outbreak or a disaster. The new WHO Health Emergencies Programme addresses the full risk management cycle, meaning it works with countries to address emergencies before they happen by working on prevention and preparedness, helps in the response to the emergency, and also, once the initial event has passed, on recovery. The new Programme builds on WHO’s years of experience working with countries in emergencies.

What is the new WHO Health Emergencies Programme?

Requested and approved by Member States, the new WHO Health Emergencies Programme is a profound change for WHO, adding operational capabilities to our traditional technical and normative roles. The Programme works with countries and partners to prepare for, prevent, respond to and recover from all hazards that create health emergencies, including disasters, disease outbreaks and conflicts. The Programme will also lead and coordinate the international health response to contain disease outbreaks and provide effective relief and recovery to affected people.

Why is the WHO Health Emergencies Programme needed?

Worldwide, a record 130 million people are in need of humanitarian assistance, and disease outbreaks are a constant global threat.

To meet the immediate health needs of crisis-affected populations at the same time as addressing the underlying causes of their vulnerability, WHO must be part of a broader change in the way the international community prevents, prepares for, and responds to crises.

What are some of the key changes and achievements within the Programme so far?

Since 1 August 2016, WHO has operated under new emergency-management processes for risk assessment, grading of emergencies and incident management. Recent emergency responses have seen the Programme continually tested and adjusted. Significant progress has been made in areas such as risk assessment and grading, coordination of WHO’s response at headquarters, regional offices and country offices through an Incident Management System, and the rapid release of funds from the WHO Contingency Fund for Emergencies. Lessons are being applied to adapt and improve the processes.

Hurricane Matthew in Haiti

In response to Hurricane Matthew in Haiti, WHO/PAHO quickly established 2 new field offices, deployed multinational teams of experts to support the government’s efforts to provide health services to affected areas, and sent essential supplies and medicines. Anticipating increased numbers of cholera outbreaks, WHO/PAHO prepositioned cholera supplies in at-risk areas. WHO/PAHO also evaluated health structures and services in Haiti to prioritize needs.

Yellow fever outbreak in Africa

WHO and partners supported the vaccination of at least 17 million people this year in response to the yellow fever outbreak in Angola and the Democratic Republic of the Congo, in complex campaigns that came together in a matter of weeks.

Response to Zika virus

Within 10 days of the declaration of Zika and its associated complications being declared a Public Health Emergency of International Concern, WHO worked with 23 agencies to develop a common strategic and operational plan. WHO’s Contingency Fund for Emergencies was used for rapid initial cash disbursement. WHO developed and rapidly distributed guidance to help countries in all aspects of the Zika response, from caring for affected infants, to eliminating mosquitoes, to strengthening health services for pregnant women living in affected areas.

Conflict in north eastern Nigeria

In north eastern Nigeria, within 6 weeks of scaling up its emergency operations, WHO supported setting up a disease alert system in 160 health facilities which serve 85% of the 1.6 million displaced people in Borno state.

How does WHO work with partners in emergencies?

The Health Emergencies Programme works with its partners to protect and save people’s lives in all health emergencies. During a crisis, WHO works with the local ministry of health and partners to identify where health needs are greatest and to coordinate the efforts of partner organizations to ensure that these areas are covered by both medical supplies and personnel.

No organization can act alone in emergencies. WHO regularly collaborates with partner networks to leverage and coordinate the expertise of hundreds of partner agencies:

  • Global Health Cluster: More than 300 partners responding in 24 crisis-affected countries.
  • Emergency Medical Teams: More than 60 teams from 25 countries classified by WHO to provide clinical care in wake of emergencies, with the number expected to rise to 200 soon.
  • Global Outbreak Alert and Response Network (GOARN): Since 2000, approximately 2 500 health personnel in response to over 130 public health emergencies in 80 countries.
  • Standby partners: In 2015, WHO’s Standby Partners deployed 207 months of personnel support to 18 countries.
  • Inter-Agency Standing Committee (IASC): WHO is an active member of IASC, the primary mechanism for inter-agency coordination relating to humanitarian assistance in response to complex and major emergencies under the leadership of the Emergency Relief Coordinator.

How does WHO’s Health Emergencies Programme support countries?

WHO’s Health Emergencies Programme provides the following services to countries:

  • support of the assessment of country health emergency preparedness and development of national plans to address critical capacity gaps;
  • development of strategies and capacities to prevent and control high-threat infectious hazards; and
  • monitoring of new and ongoing public health events to assess, communicate and recommend action for public health risks.

In addition, WHO will work with countries and partners to:

  • ensure readiness to diminish public health risks in countries with high vulnerability; and
  • provide life-saving health services to affected populations in countries with ongoing emergencies.

What is the structure of the new Programme?

The Programme has a common structure across the organization, in country offices, regional offices and headquarters. This is 1 Emergencies Programme, with

  • 1 workforce
  • 1 budget
  • 1 line of accountability
  • 1 set of processes/systems
  • 1 set of benchmarks.

The Programme’s structure reflects WHO’s major functions and responsibilities in health emergency risk assessment and management. This structure and related results expected are the same in headquarters and in regional offices and country offices.

The Programme is made up of 5 technical and operational departments. Their titles and specific outcomes are:

  • Infectious hazards management: ensure strategies and capacities are established for priority high-threat infectious hazards.
  • Country health emergency preparedness and the International Health Regulations (2005): ensure country capacities are established for all-hazards emergency risk management.
  • Health emergency information and risk assessments: provide timely and authoritative situation analysis, risk assessment and response monitoring for all major health threats and events.
  • Emergency operations: ensure emergency-affected populations have access to an essential package of life-saving health services.
  • Emergency core services: ensure WHO emergency operations are rapidly and sustainably financed and staffed.

The Programme will dedicate more than 1000 core WHO staff to work on emergencies. It will harness WHO’s experience and technical expertise on all health hazards at all levels of the Organization to coordinate the international responses to health emergencies worldwide.

How much funding is required for the new Programme?

Financing the work of the new WHO Health Emergencies Programme will require a combination of core financing for baseline staff and activities at the 3 levels of the Programme, financing of the WHO Contingency Fund for Emergencies, and financing for ongoing activities in acute and protracted emergencies through appeals guided by humanitarian response plans.

The core budget is the funding WHO needs to implement the normative, technical, and operations-management capacities and activities reflected in the new results framework for the Health Emergencies Programme. To implement the core activities of the new Health Emergencies Programme WHO must raise US$ 485 million in 2016–2017: at present a gap of 44% remains.

Funding for the core budget comes from 3 sources:

  • Assessed contributions: The annual quotas paid by Member States to support the work of the Organization.
  • Core voluntary contributions: Flexible contributions made by Member States and other donors that the Director-General may allocate at her discretion and according to need.
  • Earmarked contributions: Voluntary contributions earmarked for the core budget of the WHO Health Emergencies Programme or specific activities within it.

Appeals linked to Humanitarian Response Plans (HRPs) currently have a funding gap of 66% of the total requirement of US$ 656 million.

The third basket of funding, the WHO Contingency Fund for Emergencies (CFE), a replenishable fund which facilitates cash flow in the initial 3 months of response to an emergency (before donor funding arrives), has raised US$ 31.5 million of its US$ 100 million target.

What is the Joint External Evaluation?

The Joint External Evaluation (JEE) was developed to assist in evaluating a country’s capacity under International Health Regulations (2005) to prevent, detect, and respond to high-threat infectious hazards. The tool is arranged according to the following core elements:

  • preventing and reducing the likelihood of outbreaks and other public health hazards and events defined by International Health Regulations (2005) is essential;
  • detecting threats early can save lives; and
  • rapid, effective response requires multi-sectoral, national and international coordination and communication.

Country participation in the JEE process is voluntary, and it takes into account a multisectoral approach by both the external teams and the host countries, with an emphasis on transparency and openness of data, information sharing, and the public release of reports.

The JEE incorporates the targets and indicators of the “Global Health Security Agenda” and additional elements needed to fully cover the International Health Regulations (2005) core capacities. Countries are supported in measuring their progress in achieving the targets of the International Health Regulations (2005), ensuring any improvements can be sustained, and identifying the most urgent needs within their health security system, to prioritize opportunities for enhanced preparedness, response and action. The JEE also provides a basis for countries to engage with current and prospective donors and partners, to target resources effectively.

Who will monitor the success of the Programme?

On 29 March 2016, the Director-General established the Independent Oversight and Advisory Committee to provide oversight and monitoring of the development and performance of the WHO Health Emergencies Programme, guide the Programme’s activities, and report findings through the Executive Board to the Health Assembly. Reports of the Committee will be shared with the United Nations Secretary-General and the Inter-Agency Standing Committee.

These are the main functions of the Independent Oversight and Advisory Committee:

  • Assess the performance of the Programme’s key functions in health emergencies (including all 5 pillars of the work of the Programme, for example, including both emergency operations and core services).
  • Determine the appropriateness and adequacy of the Programme’s financing and resourcing.
  • Provide advice to the Director-General.
  • Review the Programme’s reports on WHO’s actions in health emergencies.
  • Review reports on the state of health security developed by the Director-General for submission to the World Health Assembly through the Executive Board and to the United Nations General Assembly.
  • Prepare an annual report on its activities, conclusions, recommendations, and, where necessary, interim reports, for submission by the Chair of the Committee to the World Health Assembly through the WHO Executive Board.

The Committee consists of 8 members drawn from national governments, nongovernmental organizations, and the UN system, with extensive experience in broad range of disciplines, including public health, infectious disease, humanitarian crises, public administration, emergency management, community engagement, partnerships and development. Members serve in their personal capacity and will exercise their responsibilities with full regard for the paramount importance of independence.

The Committee will regularly meet and engage with the Programme management team to help guide its work. They will also assess and influence the work of the programme through engagement with member states.


WHO: The health of displaced people in Europe

WHO

Copenhagen, Geneva, 21 January 2019

Migrants and refugees are likely to have good general health, but they can be at risk of falling sick in transition or while staying in receiving countries due to poor living conditions or adjustments in their lifestyle. This is the main conclusion of the first “Report on the health of refugees and migrants in the WHO European Region”, released by the WHO Regional Office for Europe today.

“Today, political and social systems are struggling to rise to the challenge of responding to displacement and migration in a humane and positive way. This report is the first of its kind, and gives us a snapshot of the health of refugees and migrants in the WHO European Region, at a time when the migration phenomenon is expanding across the world,” says Dr Zsuzsanna Jakab, WHO Regional Director for Europe.

The report summarizes the latest available evidence on the health of refugees and migrants in the WHO European Region – from a review of more than 13 000 documents – and the progress countries have made to promote their health. It was developed in partnership with the Italian National Institute for Health, Migration and Poverty (INMP).

Vulnerability to noncommunicable and communicable diseases

Refugees and migrants appear to be less affected than their host populations by many noncommunicable diseases on arrival; however, if they are in conditions of poverty, the duration of their stay in host countries increases their risk for cardiovascular diseases, stroke or cancer. As migrants and refugees are likely to change their lifestyle to engage in less physical activity and consume less healthy food, they are also more prone to risk factors for chronic diseases.

The displacement processes itself can make refugees and migrants more vulnerable to infectious diseases. Yet the report underlines that, for instance, the proportion of refugees and migrants among a host country’s tuberculosis (TB) cases varies broadly depending on the TB prevalence in the host population; and that a significant proportion of migrants and refugees who are HIV positive acquired the infection after they arrived in Europe. Despite the widespread assumption to the contrary, there is only a very low risk of refugees and migrants transmitting communicable diseases to their host population.

“The new report provides insight into what must be done to meet the health needs of both migrants and refugees and the host population. As migrants and refugees become more vulnerable than the host population to the risk of developing both noncommunicable and communicable diseases, it is necessary that they receive timely access to quality health services, as everyone else. This is the best way to save lives and cut treatment costs, as well as protect the health of the resident citizens,” stresses Dr Jakab.

Key findings and myths exposed

  • International migrants make up only 10% (90.7 million) of the total population in the WHO European Region. Less than 7.4% of these are refugees. In some European countries, citizens estimate that there are 3 or 4 times more migrants than there really are.
  • While communicable diseases are commonly linked with displacement and migration, there is a growing awareness that a range of acute and chronic conditions also require attention.
  • Refugees and migrants are at lower risk for all forms of cancer, except cervical cancer. However, cancer in refugees and migrants is more likely to be diagnosed at an advanced stage, which can lead to considerably worse health outcomes than those of the host population.
  • Depression and anxiety tend to affect refugees and migrants more than host populations. However, variation by migrant group and in the methods used to assess prevalence make it hard to draw firm conclusions.
  • In general, refugees and migrants have a higher incidence, prevalence and mortality rate for diabetes than the host population, with higher rates in women.
  • Refugees and migrants are potentially at greater risk of developing infectious diseases because of their exposure to infections, lack of access to health care, interrupted care and poor living conditions during the migration process. It is therefore necessary to protect them and to ensure that health-care workers on the front line understand the risks.
  • While refugees and migrants may arrive in Europe with incomplete or interrupted immunization, vaccination uptake is likely to increase with the duration of their stay. The immediate response to new arrivals is to ensure that they receive basic vaccines based on the schedule of the host country.
  • *Access to social and health services varies across the WHO European Region, with legal status, language barriers and discrimination generally being influential factors.
  • *Unaccompanied minors are vulnerable to sexual exploitation and experience higher rates of depression and symptoms of post-traumatic stress disorder.
  • *Male migrants experience significantly more work-related injuries than non-migrant workers.

A series of guidance documents was also developed to translate the report’s findings into practice. Each addresses a specific aspect of the health of refugees and migrants by providing tools, case studies and evidence to inform practices and policies to improve health. They focus on the areas of maternal and newborn health, children’s health, health promotion, mental health and healthy ageing. The documents were produced with financial support from the European Commission.

Towards refugee- and migrant-friendly health systems

Countries in the WHO European Region are making progress in implementing the Strategy and action plan for refugee and migrant health, adopted in 2016 by the WHO Regional Committee for Europe to guide progress on the health aspects of population movement. However, more needs to be done to progress towards refugee- and migrant-friendly health systems, including:

  • providing quality and affordable health coverage as well as social protection for all refugees and migrants regardless of their legal status;
  • making health systems culturally and linguistically sensitive to address communication barriers;
  • ensuring health-care workers are well equipped and experienced to diagnose and manage common infectious and noninfectious diseases;
  • enhancing multisectoral action on refugee and migrant health; and
  • improving systematic and routine collection of comparable data on refugee and migrant health.

The WHO Regional Office for Europe and partners will continue to support the implementation of the Strategy and action plan, and to assist countries in filling potential gaps in health service delivery. This includes training health-care staff, providing technical assistance, carrying out joint public health and health system assessment missions, and providing policy recommendations using the WHO toolkit to prepare for large influxes of refugees and migrants.



WHO warns against a counter­feit anti-rabies vaccine now circulating in the Philippines.

Manila Post

“….The WHO said that “two falsified vaccines have so far been discovered.” It said that Verorab vaccines with batch number NIE35 and H1833 are counterfeit.….”


WHO Humanitarian Crisis Response Plans: 2018. How successful was it and what about 2019?

WHO

The WHO Humanitarian Response Plans for 2018 are based on rigorous assessment and analysis of need in 26 countries. The plans include an overview of the situation, WHO’s objectives to address the health aspects of the crisis, and the funds that will be required to do so. They form part of the overall humanitarian response plans developed by partners in the wider humanitarian response.

Reviewing 2017 • In 2017, humanitarian agencies reached more people in need than ever before: tens of millions of them, saving millions of lives; • Donors provided record levels of funding to Humanitarian Response Plans—nearly $13 billion by the end of November; • Humanitarian agencies helped stave off famines in South Sudan, Somalia, north-east Nigeria and Yemen, through effective scale-up and the rapid release of funds by donors; • Agencies stepped up to provide rapid assistance to refugees fleeing violence in Myanmar; and • Mobilized to support countries in the Caribbean to prepare for and respond to successive hurricanes of a ferocity rarely seen before. • Despite conflict and other constraints complicating the provision of assistance, plans were implemented effectively, with costs averaging approximately $230 a year per person for essential needs.

In 2018 • Conflict will continue to be the main driver of humanitarian needs. • Protracted violence will force people to flee from their homes, deny them access to enough food, and rob them of their means of making a living. • Droughts, floods, hurricanes and other natural disasters will also create humanitarian needs. Although the risk of El Niño or La Niña is low next year, some scientists forecast an increased risk of earthquakes in 2018. • In a number of countries, humanitarian needs will fall, but still remain significant, including Afghanistan, Ethiopia, Iraq, Mali, and Ukraine. • However, needs are rising substantially in Burundi, Cameroon, Central African Republic, the Democratic Republic of the Congo, Libya, Somalia and Sudan. • And needs will remain at exceptionally high levels in Nigeria, South Sudan, the Syria region, and Yemen, which is likely to remain the world’s worst humanitarian crisis. • Overall, 136 million people across the world will need humanitarian assistance and protection. • UN-coordinated response plans costed at $22.5 billion can help 91 million. • The overall number of people in need is more than 5% higher than in the 2017 GHO. The cost of the response plans sets a new record, about 1% higher than at the start of 2017. • Humanitarian agencies will become more effective, efficient and cost-effective. They will respond faster to crises, in a way more attuned to the needs of those they are trying to help. They will undertake more comprehensive, cross-sectoral and impartial needs assessments. They will also contribute more to long-term solutions by working more closely with development agencies. • Larger country-based pooled funds will improve the agility and prioritised use of funds in the places where they operate. An expanded Central Emergency Response Fund will better support the least-funded major crises.
PEOPLE IN NEED PEOPLE TO RECEIVE AID 135.7M 90.9M
FINANCIAL REQUIREMENTS $22.5B


WHO: Ten threats to global health in 2019

WHO

The world is facing multiple health challenges. These range from outbreaks of vaccine-preventable diseases like measles and diphtheria, increasing reports of drug-resistant pathogens, growing rates of obesity and physical inactivity to the  health impacts of environmental pollution and climate change and multiple humanitarian crises.

To address these and other threats, 2019 sees the start of the World Health Organization’s new 5-year strategic plan – the 13th General Programme of Work. This plan focuses on a triple billion target:  ensuring 1 billion more people benefit from access to universal health coverage, 1 billion more people are protected from health emergencies and 1 billion more people enjoy better health and well-being. Reaching this goal will require addressing the threats to health from a variety of angles.

Here are 10 of the many issues that will demand attention from WHO and health partners in 2019.

Air pollution and climate change


Nine out of ten people breathe polluted air
every day. In 2019, air pollution is considered by WHO as the greatest environmental risk to health. Microscopic pollutants in the air can penetrate respiratory and circulatory systems, damaging the lungs, heart and brain, killing 7 million people prematurely every year from diseases such as cancer, stroke, heart and lung disease. Around 90% of these deaths are in low- and middle-income countries, with high volumes of emissions from industry, transport and agriculture, as well as dirty cookstoves and fuels in homes.The primary cause of air pollution (burning fossil fuels) is also a major contributor to climate change, which impacts people’s health in different ways. Between 2030 and 2050, climate change is expected to cause 250 000 additional deaths per year, from malnutrition, malaria, diarrhoea and heat stress.In October 2018, WHO held its first ever Global Conference on Air Pollution and Health in Geneva. Countries and organizations made more than 70 commitments to improve air quality. This year, the United Nations Climate Summit in September will aim to strengthen climate action and ambition worldwide. Even if all the commitments made by countries for the Paris Agreement are achieved, the world is still on a course to warm by more than 3°C this century.

Noncommunicable diseases

Noncommunicable diseases, such as diabetes, cancer and heart disease, are collectively responsible for over 70% of all deaths worldwide, or 41 million people. This includes 15 million people dying prematurely, aged between 30 and 69.Over 85% of these premature deaths are in low- and middle-income countries. The rise of these diseases has been driven by five major risk factors: tobacco use, physical inactivity, the harmful use of alcohol, unhealthy diets and air pollution. These risk factors also exacerbate mental health issues, that may originate from an early age: half of all mental illness begins by the age of 14, but most cases go undetected and untreated – suicide is the second leading cause of death among 15-19 year-olds.

Among many things, this year WHO will work with governments to help them meet the global target of reducing physical inactivity by 15% by 2030 – through such actions as implementing the ACTIVE policy toolkit to help get more people being active every day.

Global influenza pandemic

The world will face another influenza pandemic – the only thing we don’t know is when it will hit and how severe it will be. Global defences are only as effective as the weakest link in any country’s health emergency preparedness and response system.

WHO is constantly monitoring the circulation of influenza viruses to detect potential pandemic strains: 153 institutions in 114 countries are involved in global surveillance and response.

Every year, WHO recommends which strains should be included in the flu vaccine to protect people from seasonal flu. In the event that a new flu strain develops pandemic potential, WHO has set up a unique partnership with all the major players to ensure effective and equitable access to diagnostics, vaccines and antivirals (treatments), especially in developing countries.

Fragile and vulnerable settings

More than 1.6 billion people (22% of the global population) live in places where protracted crises (through a combination of challenges such as drought, famine, conflict, and population displacement) and weak health services leave them without access to basic care.

Fragile settings exist in almost all regions of the world, and these are where half of the key targets in the sustainable development goals, including on child and maternal health, remains unmet.WHO will continue to work in these countries to strengthen health systems so that they are better prepared to detect and respond to outbreaks, as well as able to deliver high quality health services, including immunization.

Antimicrobial resistance

The development of antibiotics, antivirals and antimalarials are some of modern medicine’s greatest successes. Now, time with these drugs is running out. Antimicrobial resistance – the ability of bacteria, parasites, viruses and fungi to resist these medicines – threatens to send us back to a time when we were unable to easily treat infections such as pneumonia, tuberculosis, gonorrhoea, and salmonellosis. The inability to prevent infections could seriously compromise surgery and procedures such as chemotherapy.

Resistance to tuberculosis drugs is a formidable obstacle to fighting a disease that causes around 10 million people to fall ill, and 1.6 million to die, every year. In 2017, around 600 000 cases of tuberculosis were resistant to rifampicin – the most effective first-line drug – and 82% of these people had multidrug-resistant tuberculosis.

Drug resistance is driven by the overuse of antimicrobials in people, but also in animals, especially those used for food production, as well as in the environment. WHO is working with these sectors to implement a global action plan to tackle antimicrobial resistance by increasing awareness and knowledge, reducing infection, and encouraging prudent use of antimicrobials.

Ebola and other high-threat pathogens

In 2018, the Democratic Republic of the Congo saw two separate Ebola outbreaks, both of which spread to cities of more than 1 million people. One of the affected provinces  is also in an active conflict zone.

This shows that the context in which an epidemic of a high-threat pathogen like Ebola erupts is critical –  what happened in rural outbreaks in the past doesn’t always apply to densely populated urban areas or conflict-affected areas.

At a conference on Preparedness for Public Health Emergencies held last December, participants from the public health, animal health, transport and tourism sectors focussed on the growing challenges of tackling outbreaks and health emergencies in urban areas. They called for WHO and partners to designate 2019 as a “Year of action on preparedness for health emergencies”.

WHO’s R&D Blueprint identifies diseases and pathogens that have potential to cause a public health emergency but lack effective treatments and vaccines. This watchlist for priority research and development includes Ebola, several other haemorrhagic fevers, Zika, Nipah, Middle East respiratory syndrome coronavirus (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS) and disease X, which represents the need to prepare for an unknown pathogen that could cause a serious epidemic.

Weak primary health care

 Primary health care is usually the first point of contact people have with their health care system, and ideally should provide comprehensive, affordable, community-based care throughout life.

Primary health care can meet the majority of a person’s health needs of the course of their life. Health systems with strong primary health care are needed to achieve universal health coverage.Yet many countries do not have adequate primary health care facilities. This neglect may be a lack of resources in low- or middle-income countries, but possibly also a focus in the past few decades on single disease programmes. In October 2018, WHO co-hosted a major global conference in Astana, Kazakhstan at which all countries committed to renew the commitment to primary health care made in the Alma-Ata declaration in 1978.

In 2019, WHO will work with partners to revitalize and strengthen primary health care in countries, and follow up on specific commitments made by in the Astana Declaration.

Vaccine hesitancy

Vaccine hesitancy – the reluctance or refusal to vaccinate despite the availability of vaccines – threatens to reverse progress made in tackling vaccine-preventable diseases. Vaccination is one of the most cost-effective ways of avoiding disease – it currently prevents 2-3 million deaths a year, and a further 1.5 million could be avoided if global coverage of vaccinations improved.

Measles, for example, has seen a 30% increase in cases globally. The reasons for this rise are complex, and not all of these cases are due to vaccine hesitancy. However, some countries that were close to eliminating the disease have seen a resurgence.The reasons why people choose not to vaccinate are complex; a vaccines advisory group to WHO identified complacency, inconvenience in accessing vaccines, and lack of confidence are key reasons underlying hesitancy. Health workers, especially those in communities, remain the most trusted advisor and influencer of vaccination decisions, and they must be supported to provide trusted, credible information on vaccines.

In 2019, WHO will ramp up work to eliminate cervical cancer worldwide by increasing coverage of the HPV vaccine, among other interventions. 2019 may also be the year when transmission of wild poliovirus is stopped in Afghanistan and Pakistan. Last year, less than 30 cases were reported in both countries. WHO and partners are committed to supporting these countries to vaccinate every last child to eradicate this crippling disease for good.

Dengue

Dengue, a mosquito-borne disease that causes flu-like symptoms and can be lethal and kill up to 20% of those with severe dengue, has been a growing threat for decades.

A high number of cases occur in the rainy seasons of countries such as Bangladesh and India. Now, its season in these countries is lengthening significantly (in 2018, Bangladesh saw the highest number of deaths in almost two decades), and the disease is spreading to less tropical and more temperate countries such as Nepal, that have not traditionally seen the disease.An estimated 40% of the world is at risk of dengue fever, and there are around 390 million infections a year. WHO’s Dengue control strategy aims to reduce deaths by 50% by 2020.

HIV

The progress made against HIV has been enormous in terms of getting people tested, providing them with antiretrovirals (22 million are on treatment), and providing access to preventive measures such as a pre-exposure prophylaxis (PrEP, which is when people at risk of HIV take antiretrovirals to prevent infection).

However, the epidemic continues to rage with nearly a million people every year dying of HIV/AIDS. Since the beginning of the epidemic, more than 70 million people have acquired the infection, and about 35 million people have died. Today, around 37 million worldwide live with HIV. Reaching people like sex workers, people in prison, men who have sex with men, or transgender people is hugely challenging. Often these groups are excluded from health services. A group increasingly affected by HIV are young girls and women (aged 15–24), who are particularly at high risk and account for 1 in 4 HIV infections in sub-Saharan Africa despite being only 10% of the population.This year, WHO will work with countries to support the introduction of self-testing so that more people living with HIV know their status and can receive treatment (or preventive measures in the case of a negative test result). One activity will be to act on new guidance announced In December 2018, by WHO and the International Labour Organization to support companies and organizations to offer HIV self-tests in the workplace.


WHO in emergencies

WHO

Grade 3 emergencies

Grade 3: a single or multiple country event with substantial public health consequences that requires a substantial WCO response and/or substantial international WHO response. Organizational and/or external support required by the WCO is substantial. An Emergency Support Team, run out of the regional office, coordinates the provision of support to the WCO.

Grade 2 emergencies

Grade 2: a single or multiple country event with moderate public health consequences that requires a moderate WCO response and/or moderate international WHO response. Organizational and/or external support required by the WCO is moderate. An Emergency Support Team, run out of the regional office (the Emergency Support Team is only run out of HQ if multiple regions are affected), coordinates the provision of support to the WCO.

Grade 1 emergencies

Grade 1: a single or multiple country event with minimal public health consequences that requires a minimal WCO response or a minimal international WHO response. Organizational and/or external support required by the WCO is minimal. The provision of support to the WCO is coordinated by a focal point in the regional office.


Categories

Recent Posts

Archives

Admin